Results 101 to 110 of about 1,254,591 (276)

Cell metabolism pathways involved in the pathophysiological changes of diabetic peripheral neuropathy

open access: yesNeural Regeneration Research
[INLINE:1] Diabetic peripheral neuropathy is a common complication of diabetes mellitus. Elucidating the pathophysiological metabolic mechanism impels the generation of ideal therapies.
Yaowei Lv   +5 more
doaj   +1 more source

Plantar pressure distribution patterns during gait in diabetic neuropathy patients with a history of foot ulcers

open access: yesClinics, 2009
OBJECTIVE: To investigate and compare the influence of a previous history of foot ulcers on plantar pressure variables during gait of patients with diabetic neuropathy.
Tatiana Almeida Bacarin   +2 more
doaj   +1 more source

Urogenital Infection Risk Associated With SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Target Trial Emulation

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Although sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are recommended for patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), concerns regarding urogenital infections persist. Therefore, we evaluated the risk of urinary tract infection (UTI) and genital tract infection (GTI) after SGLT2i initiation in this population ...
Young‐Mi Ah   +4 more
wiley   +1 more source

Artificial Intelligence in Ophthalmology: From Methodological Advances to Clinical Translation and Future Directions

open access: yesEye &ENT Research, EarlyView.
ABSTRACT Artificial intelligence (AI) is reshaping ophthalmology from task‐specific image analysis toward multimodal, longitudinal, and clinically integrated decision support. This narrative review summarizes the methodological evolution of ophthalmic AI, including traditional machine learning, task‐specific deep learning, self‐supervised learning ...
Yuxin Liu, Hanruo Liu
wiley   +1 more source

Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology
Background: There has been an increasing prevalence of diabetes worldwide. Diabetic peripheral neuropathy is the most common complication of type I and II diabetes.
Bharathi C   +3 more
doaj   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia   +2 more
wiley   +1 more source

A comparative study on cutaneous temperature difference between body and foot among patients of diabetic neuropathy and normal individuals

open access: yesAsian Journal of Medical Sciences
Background: As diabetic neuropathy progresses, the pain subsides and eventually disappears, but a sensory deficit persists and a motor deficit may develop.
Sudhir Kumar   +2 more
doaj   +1 more source

Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients

open access: yesJournal of Diabetes Research, 2018
Type 2 diabetes (T2D) accounts for about 90% of all diabetes patients and incurs a heavy global public health burden. Up to 50% of T2D patients will eventually develop neuropathy as T2D progresses.
Hong Shen   +3 more
doaj   +1 more source

The risk factors for diabetic peripheral neuropathy: A meta-analysis

open access: yesPLoS ONE, 2019
Diabetic peripheral neuropathy (DPN), the most common chronic complication of diabetes, has become an important public health crisis worldwide. Given that DPN is extremely difficult to treat, determining its risk factors and controlling it at an early ...
Xiu-juan Liu   +3 more
semanticscholar   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy